MB
MultiValent Biotherapies, Inc.
SEC filingBiotechnology · Los Altos, CA
Amount raised$10Msold at filing
Total offeringNot stated
Investors in the raise4count reported to the SEC
FiledMar 2, 2026first sale Jan 9, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Fred SchwarzerExecutive Officer, Director, Promoter
Stephen SnowdyExecutive Officer, Director, Promoter
Bruce KeytExecutive Officer, Director, Promoter
Deborah Robbins SchwarzerExecutive Officer, Director, Promoter
Executive officers, directors and promoters as listed on the Form D.